Literature DB >> 22815004

Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes.

R Matorras1, A Meabe, R Mendoza, B Prieto, O Ramón, J Mugica, F Aspichueta, A Exposito.   

Abstract

PURPOSE: The aim of our study was to ascertain the influence of hCG levels at oocyte pick-up on IVF outcomes, and their relationship with clinical parameters.
METHODS: A prospective study was performed including 473 women undergoing IVF, aged under 40 years. Blood samples to analyze hCG levels were obtained at the time of follicular aspiration, 36 h after the administration of 250 μg of recombinant hCG.
RESULTS: Neither the numbers of oocytes obtained or fertilized, nor the pregnancy rate, were correlated with hCG levels. Moreover, hCG values were very similar in women who did and did not become pregnant (123.3 ± 48.7 and 117.5 ± 44.7 mUI/mL). Cases in which no oocytes were recovered after follicular aspiration had similar hCG levels to those in which more than 1 oocyte was obtained. On the other hand, hCG levels were negatively related to body mass index, weight, and age.
CONCLUSIONS: These data indicate that after the administration of 250 μg of recombinant hCG, hCG levels are not responsible for failure to recover oocytes. Specifically, there was no correlation between plasma hCG levels and the number of oocytes obtained or other markers of IVF outcome. There was, however, an inverse relationship with BMI, body weight and age.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22815004      PMCID: PMC3492576          DOI: 10.1007/s10815-012-9826-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

1.  A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation.

Authors:  G L Driscoll; J P Tyler; J T Hangan; P R Fisher; M A Birdsall; D C Knight
Journal:  Hum Reprod       Date:  2000-06       Impact factor: 6.918

2.  Ultrasound-guided embryo transfer improves pregnancy rates and increases the frequency of easy transfers.

Authors:  R Matorras; E Urquijo; R Mendoza; B Corcóstegui; A Expósito; F J Rodríguez-Escudero
Journal:  Hum Reprod       Date:  2002-07       Impact factor: 6.918

Review 3.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

4.  Daily workload in the embryology laboratory and in vitro fertilization results.

Authors:  Antonia Expósito; Roberto Matorras; Rosario Mendoza; Lorena Crisol; Txanton Martínez-Astorquiza; Begoña Prieto
Journal:  J Reprod Med       Date:  2010 Jan-Feb       Impact factor: 0.142

5.  Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer.

Authors:  P Chang; S Kenley; T Burns; G Denton; K Currie; G DeVane; L O'Dea
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

6.  Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers.

Authors:  I Trinchard-Lugan; A Khan; H C Porchet; A Munafo
Journal:  Reprod Biomed Online       Date:  2002 Mar-Apr       Impact factor: 3.828

7.  Influence of body mass index and self-administration of hCG on the outcome of IVF cycles: a prospective cohort study.

Authors:  O Salha; T Dada; V Sharma
Journal:  Hum Fertil (Camb)       Date:  2001       Impact factor: 2.767

8.  Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.

Authors: 
Journal:  Fertil Steril       Date:  2001-06       Impact factor: 7.329

9.  Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.

Authors:  K E Elkind-Hirsch; S Bello; L Esparcia; K Phillips; A Sheiko; M McNichol
Journal:  Fertil Steril       Date:  2001-04       Impact factor: 7.329

10.  Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.

Authors:  James R Stelling; Emily T Chapman; David Frankfurter; Doria H Harris; Selwyn P Oskowitz; Richard H Reindollar
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

View more
  7 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  Human chorionic gonadotropin serum levels following ovulation triggering and IVF cycle outcome.

Authors:  Yossi Mizrachi; Eran Horowitz; Jacob Farhi; David Levran; Arieh Raziel; Ariel Weissman
Journal:  J Assist Reprod Genet       Date:  2018-03-23       Impact factor: 3.412

3.  Phase III trial comparing the efficacy and safety of recombinant- or urine-derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo-ovulation and undergoing ovulation induction with follitropin-alfa.

Authors:  Hideyuki Ikenaga; Yudai Tanaka; Masahide Shiotani; Daniela Rogoff; Shin Shimizu; Osamu Ishihara; Yoshiaki Sato; Yoshiharu Morimoto; Aisaku Fukuda; Kohzo Aisaka; Koji Yoshida; Naoki Hayashi; Hirotsugu Oku; Yuji Abe; Atsushi Haruki; Motoharu Ishikawa; Takeshi Kuramoto
Journal:  Reprod Med Biol       Date:  2016-12-04

4.  Low-Dose Urinary Human Chorionic Gonadotropin Is Effective for Oocyte Maturation in In Vitro Fertilization/ Intracytoplasmic Sperm Injection Cycles Independent of Body Mass Index.

Authors:  Luis R Hoyos; Sana Khan; Jing Dai; Manvinder Singh; Michael P Diamond; Elizabeth E Puscheck; Awoniyi O Awonuga
Journal:  Int J Fertil Steril       Date:  2016-11-11

5.  A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle® for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation.

Authors:  Abha Majumdar; Rekha Sachan; Yogeshwar S Nandanwar; Rahul V Mayekar; Neelu Soni; Manish R Banker; Rajan S Vaidya; Manjeet Arora; Girish P Godbole; Gautam V Daftary; Ganesh H Divekar; James John
Journal:  J Hum Reprod Sci       Date:  2019 Jan-Mar

6.  Recommendations for good practice in ultrasound: oocyte pick up.

Authors:  Arianna D'Angelo; Costas Panayotidis; Nazar Amso; Roberto Marci; Roberto Matorras; Mircea Onofriescu; Ahmet Berkiz Turp; Frank Vandekerckhove; Zdravka Veleva; Nathalie Vermeulen; Veljko Vlaisavljevic
Journal:  Hum Reprod Open       Date:  2019-12-10

7.  Factors predicting clinical pregnancy rate of in vitro fertilization-embryo transfer (a STROBE-compliant article).

Authors:  Yi-Le Zhang; Fu-Zhen Wang; Kai Huang; Lin-Li Hu; Zhi-Qin Bu; Jing Sun; Ying-Chun Su; Yi-Hong Guo
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.